Astrazeneca (AZN) Debt Ratio (2009 - 2026)

Astrazeneca has reported Debt Ratio for 18 years, with the latest figure at 0.16 in Q1 2026.

• On a quarterly basis, Debt Ratio fell 106.25% year-over-year to 0.16 in Q1 2026; TTM through Mar 2026 was 0.16, a 106.25% decrease from a year earlier, with the FY2025 full-year figure at 0.0, up 79.91% from the prior year.
• Debt Ratio was 0.16 for Q1 2026 at Astrazeneca, down from 0.0 in the prior quarter.
• The five-year high for Debt Ratio was 0.0 in Q4 2025, with the low at 0.16 in Q1 2026.
• Average Debt Ratio over 5 years is 0.06, with a median of 0.07 recorded in 2022.
• The largest YoY upside for Debt Ratio was 79.91% in 2025 against a maximum downside of 284.43% in 2025.
• Over 5 years, Debt Ratio stood at 0.0 in 2022, then fell by 5.84% to 0.0 in 2023, then soared by 71.75% to 0.0 in 2024, then jumped by 79.91% to 0.0 in 2025, then slumped by 138025.29% to 0.16 in 2026.
• The last three Debt Ratio figures came in at 0.16 (Q1 2026), 0.0 (Q4 2025), and 0.12 (Q3 2025), per Business Quant data.